Reduction of cellular cisplatin resistance by hyperthermia—a review

References

• Alexander H. R., Fraker D. L. Continuous hyperthermic peritoneal perfusion with cisplatin in the treatment of peritoneal carcinomatosis. Regional Cancer Treatments 1995; 8: 2–7
   Google Scholar
• Andrews P. A., Howell S. B. Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 1990; 2: 35–43
   PubMed Web of Science ®Google Scholar
• Andrews P. A., Mann S. C., Velury S., Howell S. B. Cisplatin uptake mediated cisplatin-resistance in human ovarian carcinoma cells. Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy, M. Nicolini. Martinus Nijhoff, Boston 1988; 248–254
   Google Scholar
• Andrews P. A., Mann S. C., Huynh H. H., Albright K. D. Role of the Na+, K+-adenosine triphosphatase in the accumulation of cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells. Cancer Research 1991; 51: 3677–3681
   PubMedGoogle Scholar
• Bakka A., Endresen L., Johnsen A. B. S., Edminson P. D., Rugstad H. E. Resistance against cis-dichlorodiammineplatinum in cultured cells with a high content of metallothionein. Toxicology and Applied Pharmacology 1981; 61: 215–226
   PubMed Web of Science ®Google Scholar
• Barry M. A., Behnke C. A., Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochemical Pharmacology 1990; 40: 2353–2362
   PubMed Web of Science ®Google Scholar
• Beck D. J., Popoff S., Sancar A., Rupp W. D. Reactions of the UVRABC excision nuclease with DNA damaged by diamminedichloroplatinum(II). Nucleic Acids Research 1985; 13: 7395–7412
   PubMed Web of Science ®Google Scholar
• Bohr V. A., Smith C. A., Okumoto D. S., Hanawalt P. C. DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall. Cell 1985; 40: 359–369
   PubMed Web of Science ®Google Scholar
• Bubley G. J., Xu J., Kupiec N., Sanders D., Foss F., O'Brien M., Emi Y., Teicher B. A., Patierno S. R. Effect of DNA conformation on cisplatin adduct formation. Biochemical Pharmacology 1996; 51: 717–721
   PubMedGoogle Scholar
• Caldecott K., Jeggo P. Cross-sensitivity of γ-ray-sensitive hamster mutants to cross-linking agents. Mutation Research DNA repair 1991; 255: 111–121
   PubMedGoogle Scholar
• Chao C. C., Huang S. L., Lee L. Y., Lin-Chao S. Identification of inducible damage-recognition proteins that are overexpressed in HeLa cells resistant to cis-diamminedichloroplatinum(II). Biochemical Journal 1991; 277: 875–878
   PubMed Web of Science ®Google Scholar
• Chen G., Zeller W. J. Multiple effects of 3-aminobenzamide on DNA damage induced by cisplatin (DDP) in DDP-sensitive and-resistant rat ovarian tumor cell lines. Cancer Letters 1992; 67: 27–33
   PubMedGoogle Scholar
• Chu G., Chang E. Xeroderma Pigmentosum group E cells lack a nuclear factor that binds to damaged DNA. Science 1988; 242: 564–567
   PubMedGoogle Scholar
• Chu G., Chang E. Cisplatin-resistant cells express increased levels of a factor that recognizes damaged DNA. Proceedings of the National Academy of Science, USA 1990; 87: 3324–3327
   PubMed Web of Science ®Google Scholar
• Collins A. R. Mutant rodent cell lines sensitive to ultraviolet light, ionizing radiation and cross-linking agents: a comprehensive survey of genetic and biochemical characteristics. Mutation Research DNA repair 1993; 293: 99–118
   PubMed Web of Science ®Google Scholar
• Comis R. L. Cisplatin: the future. Seminars in Oncology 1994; 21: 109–113
   PubMed Web of Science ®Google Scholar
• Dabholkar M., Bostick-Bruton F., Weber C., Bohr V. A., Egwuagu C., Reed E. ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients. Journal of the National Cancer Institute 1992; 84: 1512–1517
   PubMed Web of Science ®Google Scholar
• Dabholkar M., Vionnet J., Bostick-Bruton F., Yu J. J., Reed E. Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy. Journal of Clinical Investigation 1994; 94: 703–708
   PubMed Web of Science ®Google Scholar
• Dahl O. Interaction of heat and drugs in vitro and in vivo. Thermoradiotherapy and thermochemotherapy. Volume 1: Biology, physiology and physics, M. H. Seegenschmiedt, P. Fessenden, C. C. Vernon. Springer-Verlag, Berlin HeidelbergGermany 1995; 103–121
   Google Scholar
• Dempke W. C. M., Shellard S. A., Hosking L. K., Fichtinger-Schepman A. M. J., Hill B. T. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation. in vitro. Carcinogenesis 1992; 13: 1209–1215
   PubMedGoogle Scholar
• Eastman A. The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacological Therapeutics 1987; 34: 155–166
   PubMed Web of Science ®Google Scholar
• Eastman A., Schulte N. Enhanced repair as a mechanism of resistance to cis-diamminedichloroplatinum(II). Biochemistry 1988; 27: 4730–4734
   PubMed Web of Science ®Google Scholar
• Eichholtz-Wirth H., Hietel B. Heat sensitization to cisplatin in two cell lines with different drug sensitivities. International Journal of Hyperthermia 1990; 6: 47–55
   PubMed Web of Science ®Google Scholar
• Engelhardt R. Hyperthermia and drugs. Recent Results in Cancer Research 1987; 104: 136–203
   PubMedGoogle Scholar
• Fichtinger-Schepman A. M. J., Van Dijk-Knijnenburg H. C. M., Dijt F. J., Van der Velde-Visser S. D., Berends F., Baan R. A. Effects of thiourea and ammonium bicarbonate on the formation and stability of bifunctional cisplatin-DNA adducts: consequences for the accurate quantification of adducts in (cellular) DNA. Journal of Inorganic Biochemistry 1995; 58: 177–191
   PubMedGoogle Scholar
• Fisher G. H., Hahn G. M. Enhancement of cisplatinum (II) diamminedichloride cytotoxicity by hyperthermia. National Cancer Institute Monograms 1982; 61: 255–257
   Google Scholar
• Fraval H. N. A., Roberts J. J. Excision repair of cis-diamminedichloro-platinum(II)-induced damage to DNA of Chinese Hamster cells. Cancer Research 1979; 39: 1793–1797
   PubMed Web of Science ®Google Scholar
• Fujii R., Mutoh M., Sumizawa T., Chen Z.-S., Yoshimura A., Akiyama S.-L. Adenosine triphosphate-dependent transport of leukotriene C4 by membrane vesicles prepared from cisplatin-resistant human epidermoid carcinoma tumor cells. Journal of National Cancer Institute 1994; 86: 1781–1784
   PubMedGoogle Scholar
• Gately D. P., Howell S. B. Cellular accumulation of the anticancer agent cisplatin: A review. British Journal of Cancer 1993; 67: 1171–1176
   PubMed Web of Science ®Google Scholar
• Goto S., Yoshida K., Morikawa T., Urata Y., Suzuki K., Kondo T. Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells. Cancer Research 1995; 55: 4297–4301
   PubMedGoogle Scholar
• Hahn G. M. Hyperthermia and Cancer. Plenum Press, New York and London 1982
   Google Scholar
• Henle K. J. Sensitization to hyperthermia below 43 degrees C induced in Chinese hamster ovary cells by step-down heating. Journal of National Cancer Institute 1980; 64: 1479–1483
   PubMedGoogle Scholar
• Herman T. S., Sweets C. C., White D. M., Gerner E. W. Effect of heating rate on lethality due to hyperthermia and selected chemotherapeutic drugs. Journal of National Cancer Institute 1982; 68: 487–491
   PubMedGoogle Scholar
• Herman T. S., Henle K. J., Nagle W. A., Moss A. J., Monson T. T. Effect of step-won heating on the cytotoxicity of adriamycin, bleomycin, and cis-diamminedichloroplatinum. Cancer Research 1984; 44: 1823–1826
   PubMed Web of Science ®Google Scholar
• Herman T. S., Teicher B. A., Cathcart K. N. S., Kaufmann M. E., Lee J. B., Lee M.-H. Effect of hyperthermia on cis-diamminedichloroplatinum(II) and (rhodamine 123)2[tetrachloro-platinum(II)] in human squamous cell carcinoma line and a cis-diamminedichloroplatinum(II) resistant subline. Cancer Research 1988; 48: 5101–5105
   PubMed Web of Science ®Google Scholar
• Herman T. S., Teicher B. A. Summary of studies adding systemic chemotherapy to local hyperthermia and radiation. International Journal of Hyperthermia 1994; 10: 443–449
   PubMed Web of Science ®Google Scholar
• Hettinga J. V. E., Lemstra W., Meijer C., Mulder N. H., Konings A. W. T., De Vries E. G. E., Kampinga H. H. Hyperthermic potentiation of cisplatin toxicity in a human small cell lung carcinoma cell line and a cisplatin resistant subline. International Journal of Hyperthermia 1994; 10: 795–805
   PubMed Web of Science ®Google Scholar
• Hettinga J. V. E., Lemstra W., Konings A. W. T., Kampinga H. H. Cisplatin sensitivity and thermochemosensitization in thermotolerant cDDP-sensitive and-resistant cell lines. British Journal of Cancer 1995a; 71: 498–504
   PubMedGoogle Scholar
• Hettinga J. V. E., Lemstra W., De Vries E. G. E., Konings A. W. T., Kampinga H. H. Sensitization to cisplatin action by step-down heating in cDDP-sensitive and-resistant cells. International Journal of Cancer 1995b; 61: 722–726
   PubMedGoogle Scholar
• Hettinga J. V. E. Reduction of cisplatin resistance by hyperthermia. PrintPartners Ipskamp bv, Enschede 1996, PhD Thesis, Univ. of Groningen, ISBN 90–367–0648–3
   Google Scholar
• Hettinga J. V. E., Lemstra W., Meijer C., Dam W. A., Uges D. R. A., Konings A. W. T., De Vries E. G. E., Kampinga H. H. Mechanism of hyperthermic potentiation of cisplatin action in cisplatin sensitive and-resistant tumor cells. British Journal of Cancer 1997; 75: 1735–1743
   PubMed Web of Science ®Google Scholar
• Hill B. T., Scanlon K. J., Hansson J., Harstrick A., Pera M., Fichtinger-Schepman A. M. J., Shellard S. A. Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patients. Cancer 1994; 30: 832–837
   Google Scholar
• Hoeijmakers J. H. J. Nucleotide excision repair II: from yeast to mammals. Trends in Genetics 1993; 9: 211–217
   PubMed Web of Science ®Google Scholar
• Huang J. C., Zamble D. B., Reardon J. T., Lippard S. J., Sancar A. HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the antic-ancer drug cisplatin by human excision nuclease. Proceedings of the National Academy of Science USA 1994; 91: 10394–10938
   PubMed Web of Science ®Google Scholar
• Ishida H., Kijima H., Ohta Y., Kashani-Sabet M., Scanlon K. J. Mechanisms of cisplatin resistance and its reversal in human tumors. Mechanisms and reversal of multidrug resistance in cancer: the other alternatives, J. A. Kellen. Birkhäuser, Boston, MAUSA 1995
   Google Scholar
• Ishikawa T., Ali-Osman F. Glutathione-associated cis-diamminedichloro-platinum(II) metabolism and ATP-dependent efflux from leukemia cells. Journal of Biological Chemistry 1993; 268: 20116–20125
   PubMed Web of Science ®Google Scholar
• Ishikawa T., Wright C. D., Ishizuka H. GS-X pump is functionally overex-pressed in cis-diamminedichloroplatinum(II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation. Journal of Biological Chemistry 1994; 269: 29085–29093
   PubMed Web of Science ®Google Scholar
• Jones J. C., Zhen W., Reed E., Parker R. J., Sancar A., Bohr V. A. Genespecific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese Hamster Ovary cells. Journal of Biological Chemistry 1991; 266: 7107–7107
   Google Scholar
• Kampinga H. H. Effects of hyperthermia on chromatin organization: consequences for DNA repair and radiosensitivity. Congress Proceedings of the Tenth International Congress of Radiation Research Würzburg Germany, Vol. 2: Congress Lectures. 1995, U. Hagen, H. Jung, C. Streffer. WürzburgGermany
   Google Scholar
• Kelland L. R., Mistry P., Abel G., Freidlos F., Loh S. Y., Roberts J. J., Harrap K. R. Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line. Cancer Research 1992; 52: 1710–1716
   PubMed Web of Science ®Google Scholar
• Kelley S. L., Rozencweig M. Resistance to platinum compounds: mechanisms and beyond. European Journal of Cancer Clinical Oncology 1989; 25: 1135–1140
   PubMedGoogle Scholar
• Kelley S. L., Basu A., Thicker B. A., Hacker M. P., Hamer D. H., Lazo J. S. Overexpression of metallothionein confers resistance to anticancer drugs. Science 1988; 241: 1813–1815
   PubMed Web of Science ®Google Scholar
• Konings A. W. T. Membranes as targets for hyperthermic cell killing. Recent Results in Cancer Research 1988; 109: 9–21
   PubMedGoogle Scholar
• Konings A. W. T., Hettinga J. V. E., Lemstra W., Humphrey G. B., Kampinga H. H. Sensitizing for cis-diamminedicholoroplatinum(II) action by hyperthermia in resistant cells. International Journal of Hyperthermia 1993; 9: 553–562
   PubMed Web of Science ®Google Scholar
• Lai G.-M., Ozols R. F., Smyth J. F., Young R. C., Hamilton T. C. Enhanced DNA repair and resistance to cisplatin in human ovarian cancer. Biochemical Pharmacology 1988; 37: 4597–4600
   PubMed Web of Science ®Google Scholar
• Laszlo A. The effects of hyperthermia on mammalian cell structure and function. Cell Proliferation 1992; 25: 59–87
   PubMed Web of Science ®Google Scholar
• Leopold K. A., Oleson J. R., Clarke-Pearson D., Soper J., Berchuck A., Samulski T., Page R. L., Blivin J., Tomberlin J. K., Dewhirst M. W. Intraperitoneal cisplatin and regional hyperthermia for ovarian carcinoma. International Journal of Radiation Oncology, Biology and Physics 1993; 27: 1245–1251
   PubMed Web of Science ®Google Scholar
• Lehmann A. R. Nucleotide excision repair and the link with transcription. Trends in Biochemical Science 1995; 237: 402–405
   Google Scholar
• Lindegaard J. C., Radacic M., Khalil A. A., Horsman M. R., Overgaard J. Cisplatin and hyperthermia treatment of a C3H mammary carcinoma. in vivo. Acta Oncologica 1992; 31: 347–351
   PubMed Web of Science ®Google Scholar
• Los G., Van den Vugt M. J. H., Engelse L., Pinedo H. M. Effects of temperature on the interaction of cisplatin and carboplatin with cellular DNA. Biochemical Pharmacology 1993; 46: 1229–1237
   PubMed Web of Science ®Google Scholar
• Majima H., Kashiwado K., Egawa S., Suzuki N., Urano M. Interaction between the kinetics of thermotolerance and effect of cis-diamminedichloro-platinum(II) or bleomycin given at 37 or 43°C. International Journal of Hyperthermia 1992; 8: 431–442
   PubMed Web of Science ®Google Scholar
• Mansouri A., Henle K. J., Benson A. M., Moss A. J., Nagle W. A. Characterization of a cisplatin-resistant subline of murine RIF-1 cells and reversal of drugresistance by hyperthermia. Cancer Research 1989; 49: 2674–2678
   PubMed Web of Science ®Google Scholar
• May A., Nairn R. S., Okumoto D. S., Wasserman K., Stevnsner T., Jones J. C., Bohr V. A. Repair of individual DNA strands in the hamster dihydrofolate reductase gene after treatment with ultraviolet light, alkylating agents, and cisplatin. Journal of Biological Chemistry 1993; 268: 1650–1657
   PubMedGoogle Scholar
• Meijer C., Mulder N. H., De Vries E. G. E. The role of detoxifying systems in resistance of tumor cells to cisplatin and adriamycin. Cancer Treatment Review 1990; 17: 389–407
   PubMed Web of Science ®Google Scholar
• Meijer C., Mulder N. H., Timmer-Bosscha H., Sluiter W. J., Meersma G. J., De Vries E. G. E. Relationship of cellular glutathione to the cytotoxicity and the resistance of seven platinum compounds. Cancer Research 1992; 52: 6885–6889
   PubMed Web of Science ®Google Scholar
• Mellon I., Hanawalt P. C. Induction of the Escherichia coli lactose operon selectively increases repair of its transcribed strand. Nature 1989; 342: 95–98
   PubMed Web of Science ®Google Scholar
• Meyn R. E., Corry P. M., Fletcher S. E., Demetriades M. Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloro-platinum(II). Cancer Research 1980; 40: 1136–1139
   PubMed Web of Science ®Google Scholar
• Ohno S., Siddik Z. H., Kido Y., Zwelling L. A., Bull J. M. C. Thermal enhancement of drug uptake and DNA adducts as a possible mechanism for the effect of sequencing hyperthermia on cisplatin-induced cytotoxicity in L1210 cells. Cancer Chemotherapy and Pharmacology 1994; 34: 302–306
   PubMed Web of Science ®Google Scholar
• Ormerod M. G., O'Neill C., Robertson D., Kelland L. R., Harrap K. R. Cis-diamminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines. Cancer Chemotherapy and Pharmacology 1996; 37: 463–471
   PubMed Web of Science ®Google Scholar
• Page J. D., Husain L., Sancar A., Chaney S. G. Effect of the diaminocyclo-hexane carrier ligand on platinum adduct formation, repair and lethality. Biochemistry 1990; 29: 1016–1024
   PubMed Web of Science ®Google Scholar
• Perego P., Giarola M., Righetti S. C., Supino R., Caserini C., Delia D., Pierotti M. A., Miyashita T., Reed J. C., Zunino F. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Cancer Research 1996; 56: 556–562
   PubMed Web of Science ®Google Scholar
• Plooy A. C. M., Van Dijk M., Berends F., Lohman P. H. M. Formation and repair of DNA interstrand crosslinks in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II). Cancer Research 1985; 45: 4178–4184
   PubMedGoogle Scholar
• Rampino N. J., Bohr V. A. Rapid gene-specific repair of cisplatin lesions at the human DUG/DHFR locus compromising the divergent upstream gene and dihydro-folate reductase gene during early GI phase of the cell cycle assayed by using the exonucleolytic activity of T4 DNA polymerase. Proceedings of the National Academy of Science, USA 1994; 91: 10977–10981
   PubMedGoogle Scholar
• Rietbroek R. C., Barker P. J. M., Schilthuis M. S., Postma A. J., Zum Vörde Sive Vörding P. J., Gonzalez Gonzalez D., Kurth K.-H., Barker A. J., Veenhof C. H. N. Feasibility, toxicity, and preliminary results of weekly loco-regional hyperthermia and cisplatin in patients with previously irradiated recurrent cervical carcinoma or locally advanced bladder cancer. International Journal of Radiation Biology and Physics 1996; 34: 887–893
   PubMed Web of Science ®Google Scholar
• Sakkers R. J., Filon A. R., Brunsting J. F., Kampinga H. H., Mullenders L. H. F., Konings A. W. T. Heat-shock treatment selectively affects induction and repair of cyclobutane pyrimidine dimers in transcriptionally active genes in ultraviolet-irradiated human fibroblasts. Radiation Research 1993; 135: 343–350
   PubMed Web of Science ®Google Scholar
• Sakkers R. J., Filon A. R., Kampinga H. H., Konings A. W. T., Mullenders L. H. Repair of UV-induced pyrimidine (6–4) pyrimidone photoproducts is selectively inhibited in transcriptionally active genes after heat treatment of human fibroblasts. International Journal of Radiation Biology 1995a; 67: 495–499
   PubMed Web of Science ®Google Scholar
• Sakkers R. J., Filon A. R., Brunsting J. F., Kampinga H. H., Konings A. W. T., Mullenders L. H. Selective inhibition of repair of active genes by hyperthermia is due to inhibition of global and transcription coupled repair pathways. Carcinogenesis 1995b; 16: 743–748
   PubMed Web of Science ®Google Scholar
• Scanlon K. J., Kashani-Sabet M., Miyachi H., Sowers L. C., Rossi J. Molecular basis of cisplatin resistance in human carcinomas: model systems and patients. Anticancer Research 1989; 9: 1301–1312
   PubMedGoogle Scholar
• Schilder R. J., Hall L., Monks A., Handel L. M., Fornace A. J., Ozols R. F., Fojo A. T., Hamilton T. C. Metallothionein gene expression and resistance to cisplatin in human ovarian cancer. International Journal of Cancer 1990; 45: 416–422
   PubMed Web of Science ®Google Scholar
• Schmidt W. J., Chaney S. G. Role of carrier ligand in platinum resistance of human carcinoma cell lines. Cancer Research 1993; 53: 799–805
   PubMed Web of Science ®Google Scholar
• Shivji M. K. K., Kenny M. K., Wood R. D. Proliferating cell nuclear antigen is required for DNA excision repair. Cell 1992; 69: 367–374
   PubMed Web of Science ®Google Scholar
• Sorenson C. M., Barry M. A., Eastman A. Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. Journal of the National Institute of Cancer Institute 1990; 82: 749–755
   PubMed Web of Science ®Google Scholar
• Takahashi I., Maehara Y., Kusumoto H., Kohnoe S., Sugimachi K. Heat enhances the cytotoxicity of cis-diamminedichloroplatinum(II) and its analogues cis-1, 1-cyclobutane-dicarboxylato(2R)-2-methyl-1, 4-butanediammineplatinum(II) and cis-diammine (glycolato) platinum. in vitro. Cancer Chemotherapy and Pharmacology 1993; 33: 31–35
   PubMedGoogle Scholar
• Taverna P., Hansson J., Scanlon K. J., Hill B. T. Gene expression in X-irradiated human tumour cell lines expressing cisplatin resistance and altered DNA repair capacity. Carcinogenesis 1994; 15: 2053–5056
   PubMed Web of Science ®Google Scholar
• Tebbs R. S., Zhao Y., Tucker J. D., Scheerer J. B., Siciliano M. J., Hwang M., Liu N., Legerski R. J., Thompson L. H. Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene. Proceedings of National Academy of Science, USA 1995; 92: 6354–6358
   PubMed Web of Science ®Google Scholar
• Teicher B. A., Herman T. S. Antitumor chemotherapy with hyperthermia and radiation trimodality therapy. Hyperthermia and Oncology, vol. 4: Chemopotentiation by hyperthermia, M. Urano, E. Douple. VSP, UtrechtThe Netherlands 1994; 115–168
   Google Scholar
• Timmer-Bosscha H., Mulder N. H., De Vries E. G. E. Modulation of cis-diamminedichloroplatinum(II) resistance: a review. British Journal of Cancer 1992; 66: 227–238
   PubMed Web of Science ®Google Scholar
• Urano M., Kahn J., Kenton L. A. The effect of cisdiamminedichloro-platinum(II) treatment at elevated temperatures on murine fibrosarcoma, FSa-II. International Journal of Hyperthermia 1990; 6: 563–570
   PubMed Web of Science ®Google Scholar
• Venema J., Van Hoffen A., Natarajan A. T., Van Zeeland A. A., Mullenders L. H. F. The residual repair capacity of xeroderma pigmentosum complementation group C fibroblasts is highly specific for transcriptionally active DNA. Nuclear Acids Research 1990; 18: 443–448
   PubMedGoogle Scholar
• Wallner K. E., Degregorio M. W., Li G. C. Hyperthermic potentiation of cis-diamminedichloroplatinum(II) cytotoxicity in Chinese Hamster Ovary cells resistant to the drug. Cancer Research 1986; 46: 6242–6245
   PubMed Web of Science ®Google Scholar
• Wosikowski K., Regis J. T., Robey R. W., Alvarez M., Buters J. T. M., Gudas J. M., Bates S. E. Normal p53 status and function despite the development of drug resistance in human breast cancer cells. Cell Growth and Differentiation 1995; 6: 1395–1403
   PubMedGoogle Scholar
• Yamazaki H., Schneider E., Myers C. E., Sinha B. K. Oncogene overexpression and de novo drug-resistance in human prostate cancer cells. Biochimica et Biophysica Acta 1994; 1226: 89–96
   PubMedGoogle Scholar
• Yano T., Nakatani K., Watanabe A., Nakano H., Ohnishi T. Effects of preheating on cis-diamminedichloroplatinum(II)-hyperthermia-induced tumour growth depression of transplantable human oesophageal cancer to nude mice. International Journal of Hyperthermia 1993; 9: 699–708
   PubMed Web of Science ®Google Scholar
• Yao K.-S., Godwin A. K., Johnson S. W., Ozols R. F., O'Dwyer P. J., Hamilton T. C. Evidence for altered regulation of γ-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines. Cancer Research 1995; 55: 4367–4374
   PubMed Web of Science ®Google Scholar